FDA Drug Recalls

Recalls / Class III

Class IIID-0291-2015

Product

Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01

Affected lot / code info
Lot ET5122, Exp. 10/17

Why it was recalled

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Recalling firm

Firm
Sandoz Incorporated
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, N/A, Broomfield, Colorado 80020-1632

Distribution

Quantity
1,008 bottles
Distribution pattern
AZ

Timeline

Recall initiated
2014-12-05
FDA classified
2014-12-09
Posted by FDA
2014-12-17
Terminated
2015-06-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0291-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.